Home › BIO says Kyle Bass continues abuse of patent challenge system.
 

Keywords :   


BIO says Kyle Bass continues abuse of patent challenge system.

2015-09-09 14:31:10| Industrial Newsroom - All News for Today

According to statement by BIO President and CEO Jim Greenwood, billionaire hedge fund manager Kyle Bass continues to attack biotechnology companies with endless Inter Parte Review challenges to legitimate patents. Four new IPR filings against Acorda Therapeutics are particularly egregious, coming on the heels of Bass’ prior failed attempt to attack 2 of those same patents covering multiple sclerosis drug Ampyra. BIO again calls on PTO and Congress to quickly take action to stop this abuse.

Tags: system abuse challenge continues

Category:Industrial Goods and Services

Latest from this category

All news
01.05Will Artificial Intelligence Be the End of Reps? Part 2
Industrial Goods and Services »
13.05BASF in South Carolina Joins with Make-A-Wish
13.05PCMC addresses latest printing trends at \'Power Packs Live\'
13.05More than 50 sessions scheduled for drupa cube
13.05IDENTCO highlights automation and PCB labeling at PCB East
13.05Piracy on social media and messaging apps grows in Asia Pacific
13.05Anoki launches AI-powered experience on Google TV
13.05INDA, AFS Partner on FiltXPO 2025 Conference Program
13.05Swisscom TV connections down 11,000 in 1Q 2024
More »